Reduction of Insulin Resistance by Momordica Charantia with Lactobacillus Acidophilus CBT-LA1 or Lactiplantibacillus Plantarum CBT-LP3 Improves Hepatosteatosis

키워드

참고문헌 (54)

1. Clemente-Suárez VJ, "Global impacts of Western diet and its effects on metabolism and health : A narrative review", Nutrients, 15, pp.2749~ (2023)
2. Goldstein BJ, "Insulin resistance as the core defect in type 2diabetes mellitus", Am. J. Cardiol, 90, pp.3~10 (2002)
3. Kumar S, "Insulin resistance. Insulin action and its disturbances in disease" (2005), Chichester
4. Kahn S, "Mechanisms linking obesity to insulin resistance and type 2 diabetes", Nature, 444, pp.840~846 (2006)
5. Kahn, "The importance of β-cell failure in the development and progression of type 2 diabetes", J. Clin. Endocrinol. Metab, 86, pp.4047~4058 (2001)
6. Weyer C, "Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development", Clin. Diabetol, 2, pp.167~172 (2001)
7. Tsapas A, "Comparative effectiveness of glucoselowering drugs for type 2 diabetes : a systematic review and network meta-analysis", Annal. Int. Med, 173, pp.278~286 (2020)
8. Waugh N, "Newer agents for blood glucose control in type 2 diabetes : systematic review and economic evaluation", Health Technol. Assess, 14, pp.1~248 (2010)
9. Mastrototaro L, "Insulin resistance and insulin sensitizing agents", Metabolism, 125, pp.154892~ (2021)
10. Richter E, "The effects of Momordica charantia on type 2 diabetes mellitus and Alzheimer’s disease", Int. J. Mol. Sci, 24, pp.4643~ (2023)
11. Kim YA, "Probiotics, prebiotics, synbiotics and insulin sensitivity", Nutr. Res. Rev, 31, pp.35~51 (2018)
12. Wang G, "Lactic acid bacteria reduce diabetes symptoms in mice by alleviating gut microbiota dysbiosis and inflammation in different manners", Food Funct, 11, pp.5898~5914 (2020)
13. Honda K, "Anti-diabetic effects of lactic acid bacteria in normal and type 2 diabetic mice", J. Clin. Biochem. Nutr, 51, pp.96~101 (2012)
14. Moon H, "The effect of fermented Momordica charantia with Leuconostoc mesenteroides MKSR on metabolic complications induced by highfat high-cholesterol diet in C57BL", 6 mice, 2023, pp.9, 718~
15. Hartajanie L, "Probiotics fermented bitter melon juice as promising complementary agent for diabetes type 2 : study on animal model", J. Nutr. Metab, 2020, pp.6369873~ (2020)
16. Kim J, "Enhancement of bioactive properties in Momordica charantia by Leuconostoc fermentation", Fermentation, 9, pp.523~ (2023)
17. Lim TJ, "Effects of multi-species probiotic supplementation on alcohol metabolism in rats", J. Microbiol, 59, pp.417~425 (2021)
18. Rahman IU, "Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients", Nutr. J, 14, pp.13~ (2015)
19. Liang W, "Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology", PLoS One, 9, pp.e115922~ (2014)
20. Geng Y, "How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?", Hepatol. Int, 15, pp.21~35 (2021)
21. Ipsen DH, "Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease", Cell. Mol. Life Sci, 75, pp.3313~3327 (2018)
22. Skyler JS, "Diabetes mellitus : pathogenesis and treatment strategies", J. Med. Chem, 47, pp.4113~4117 (2004)
23. Singh VP, "An overview on anti diabetic drugs and development", Sci. Technol. J, 4, pp.113~123 (2016)
24. Li M, "Trends in insulin resistance : Insights into mechanisms and therapeutic strategy", Signal Transduct. Target. Ther, 7, pp.216~ (2022)
25. Kazeem MI, "Anti-diabetic functional foods as sources of insulin secreting, insulin sensitizing and insulin mimetic agents", J. Funct. Foods, 20, pp.122~138 (2016)
26. Shih CC, "Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet", Diabetes Res. Clin. Pract, 81, pp.134~143 (2008)
27. Alam MA, "Beneficial role of bitter melon supplementation in obesity and related complications in metabolic syndrome", J. Lipids, 2015, pp.496169~ (2015)
28. Leung L, "Anti-diabetic and hypoglycaemic effects of Momordica charantia(bitter melon) : a mini review", Br. J. Nutr, 102, pp.1703~1708 (2009)
29. Joseph B, "Antidiabetic effects of Momordica charantia(bitter melon)and its medicinal potency", Asian Pacific J. Trop. Dis, 3, pp.93~102 (2013)
30. Fuangchan A, "Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients", J. Ethnopharmacol, 134, pp.422~428 (2011)
31. Salles BIM, "Probiotics supplementation and insulin resistance : A systematic review", Diabetol. Metab. Syndr, 12, pp.98~ (2020)
32. Yan F, "Lactobacillus acidophilus alleviates type 2 diabetes by regulating hepatic glucose, lipid metabolism and gut microbiota in mice", Food Funct, 10, pp.5804~5815 (2019)
33. Andreasen AS, "Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects", Br. J. Nnutr, 104, pp.1831~1838 (2010)
34. Lee YS, "Lactobacillus plantarum HAC01 ameliorates type 2 diabetes in high-fat diet and streptozotocin-induced diabetic mice in association with modulating the gut microbiota", Food Funct, 12, pp.6363~6373 (2021)
35. Lee E, "Lactobacillus plantarum strain Ln4 attenuates diet-induced obesity, insulin resistance, and changes in hepatic mRNA levels associated with glucose and lipid metabolism", Nutrients, 10, pp.643~ (2018)
36. Wu T, "Lactobacillus rhamnosus LRa05 ameliorate hyperglycemia through a regulating glucagon-mediated signaling pathway and gut microbiota in type 2 diabetic mice", J. Agric. Food Chem, 69, pp.8797~8806 (2021)
37. Kim SW, "Lactobacillus rhamnosus GG improves insulin sensitivity and reduces adiposity in high-fat diet-fed mice through enhancement of adiponectin production", Biochem. Biophys. Res. Commun, 431, pp.258~263 (2013)
38. Kim J, "Enhancement of bioactive properties in Momordica charantia by leuconostoc fermentation", Fermentation, 9, pp.523~ (2023)
39. Yousaf S, "Hypoglycemic and hypolipidemic effects of Lactobacillus fermentum, fruit extracts of Syzygium cumini and Momordica charantia on diabetes induced mice", Pak. J. Pharm. Sci, 29, pp.1535~1540 (2016)
40. Su N, "Quality properties, flavor and hypoglycemia activity of Kiwifruit-Bitter gourd fermented milks", Food Biosci, 22, pp.139~145 (2018)
41. Day C, "Hypoglycaemic effect of Momordica charantia extracts", Planta Med, 56, pp.426~429 (1990)
42. Chen Q, "Reduced adiposity in bitter melon(Momordica charantia)fed rats is associated with lower tissue triglyceride and higher plasma catecholamines", Br. J. Nutr, 93, pp.747~754 (2005)
43. Çakici Í, "Hypoglycaemic effect of Momordica charantia extracts in normoglycaemic or cyproheptadine-induced hyperglycaemic mice", J. Ethnopharmacol, 44, pp.117~121 (1994)
44. Bano F, "Effect of the aqueous extract of Momordica charantia on body weight of rats", J. Basic Appl. Sci, 7, pp.1~5 (2011)
45. Ansari P, "Insulin secretory actions of polyphenols of Momordica charantia regulate glucose homeostasis in alloxaninduced type 2 diabetic rats", RPS Pharm. Pharmacol. Rep, 3, pp.rqae005~ (2024)
46. Tang AN, "Effects of insulin glargine and liraglutide therapy on liver fat as measured by magnetic resonance in patients with type 2 diabetes : a randomized trial", Diabetes Care, 38, pp.1339~1346 (2015)
47. Li Y, "Effects of short-term therapy with different insulin secretagogues on glucose metabolism, lipid parameters and oxidative stress in newly diagnosed type 2 diabetes mellitus", Diabetes Res. Clin. Pract, 88, pp.42~47 (2010)
48. Mori Y, "Role of early insulin secretion in postglucose-loading hyperglycaemia and postfat-loading hyperlipidaemia : comparing nateglinide and glibenclamide for acute effects on insulin secretion in OLETF rats", Diabetes Obes Metab, 6, pp.422~431 (2004)
49. Ai M, "Favorable effects of early insulin secretion by nateglinide on postprandial hyperlipidemia in patients with type 2 diabetes", Diabetes Care, 29, pp.1180~1181 (2006)
50. Kim DJ, "Lactobacillus rhamnosus CBT-LR5 improves lipid metabolism by enhancing Vitamin absorption", Microbiol. Biotechnol. Lett, 50, pp.477~487 (2022)
51. Shiba, T., "Improvement of insulin resistance by a new insulin secretagogue, nateglinide-analysis based on the homeostasis model", Diabetes Res. Clin. Pract, 62, pp.87~94 (2003)
52. Sridhar MG, "Bitter gourd(Momordica charantia)improves insulin sensitivity by increasing skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat-fed rats", Br. J. Nutr, 99, pp.806~812 (2008)
53. Shih CC, "Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats", J. Ethnopharmacol, 123, pp.82~90 (2009)
54. Yang SJ, "Preventive effects of bitter melon(Momordica charantia)against insulin resistance and diabetes are associated with the inhibition of NF-κB and JNK pathways in high-fat-fed OLETF rats", J. Nutr. Biochem, 26, pp.234~240 (2015)

관련 논문AI추천